World's Best Scientists 2026 revealed!
Award Badge
Rising Stars
2025

D-Index & Metrics

Rising Stars

D-Index
52
Citations
10427
World Ranking
269
National Ranking
46

Molecular Biology

D-Index
53
Citations
11994
World Ranking
2379
National Ranking
1177

Henry W. Long publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Henry W. Long sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 333 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Henry W. Long D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Henry W. Long sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 53 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Rising Stars Award

Overview

Henry W. Long is affiliated with Harvard University in the United States, where their work primarily spans the disciplines of Biochemistry, Genetics, and Molecular Biology, with extensive contributions to Medicine. Their research focuses on several subfields including Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, and Immunology.

Long's main topics of study cover a range of areas related to cancer and genetics. These include Epigenetics and DNA Methylation, Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, Genomics and Chromatin Dynamics, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers, and Lung Cancer Research Studies.

Their recent notable publications include:

  • Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway, 2020, Cancer Cell
  • Prostate cancer reactivates developmental epigenomic programs during metastatic progression, 2020, Nature Genetics
  • Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade, 2021, Cancer Discovery
  • EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer, 2021, Nature Cancer
  • Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer, 2020, Cancer Research

Frequent co-authors who have collaborated extensively with Long include:

  • Paloma Cejas
  • Xintao Qiu
  • Myles Brown
  • Yingtian Xie
  • Matthew L. Freedman

Long's work has been regularly published in venues such as Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), Nature Communications, Cancer Cell, and Nature Genetics. Their publication record shows a considerable focus on high-impact journals related to cancer and molecular biology research.

Best Publications

  • Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance

    Sheng Yu Ku;Spencer Rosario;Yanqing Wang;Ping Mu

  • A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing

    Deng Pan;Aya Kobayashi;Aya Kobayashi;Peng Jiang;Lucas Ferrari de Andrade

  • Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

    Shaokun Shu;Charles Y. Lin;Housheng Hansen He;Robert M. Witwicki

  • The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis

    Mark M Pomerantz;Fugen Li;David Y Takeda;David Y Takeda;Romina Lenci

  • HIF1A Employs CDK8-Mediator to Stimulate RNAPII Elongation in Response to Hypoxia

    Matthew D. Galbraith;Mary A. Allen;Claire L. Bensard;Xiaoxing Wang;Xiaoxing Wang

  • Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.

    Kari J. Kurppa;Yao Liu;Ciric To;Tinghu Zhang

  • The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

    Elizabeth C. Townsend;Mark A. Murakami;Alexandra Christodoulou;Amanda L. Christie

  • A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer

    David Y. Takeda;David Y. Takeda;Sándor Spisák;Ji Heui Seo;Connor Bell

  • Broadly permissive intestinal chromatin underlies lateral inhibition and cell plasticity

    Tae-Hee Kim;Fugen Li;Isabel Ferreiro-Neira;Isabel Ferreiro-Neira;Li-Lun Ho;Li-Lun Ho

  • Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations

    Rinath Jeselsohn;Rinath Jeselsohn;Johann S. Bergholz;Matthew Pun;MacIntosh Cornwell

  • Refined DNase-seq protocol and data analysis reveals intrinsic bias in transcription factor footprint identification

    Housheng Hansen He;Clifford A. Meyer;Sheng'En Shawn Hu;Sheng'En Shawn Hu;Mei Wei Chen

  • Prostate cancer reactivates developmental epigenomic programs during metastatic progression

    Mark M. Pomerantz;Xintao Qiu;Yanyun Zhu;David Y. Takeda;David Y. Takeda

  • VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis

    MacIntosh I. Cornwell;Mahesh Vangala;Len Taing;Zachary Herbert

  • Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.

    Shengqing Stan Gu;Wubing Zhang;Wubing Zhang;Xiaoqing Wang;Peng Jiang

  • EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer.

    Katherine L. Morel;Anjali V. Sheahan;Deborah L. Burkhart;Sylvan C. Baca

  • Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer.

    Neel Shah;Ping Wang;John Wongvipat;Wouter R Karthaus

  • ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer.

    Laura Cato;Jonas de Tribolet-Hardy;Jonas de Tribolet-Hardy;Irene Lee;Jaice T. Rottenberg

  • Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.

    Paloma Cejas;Yotam Drier;Yotam Drier;Yotam Drier;Koen M.A. Dreijerink;Lodewijk A.A. Brosens

  • Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer

    Shaokun Shu;Hua-Jun Wu;Jennifer Y. Ge;Jennifer Y. Ge;Rhamy Zeid

  • Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

    Shaokun Shu;Charles Y. Lin;Housheng Hansen He;Robert M. Witwicki

Frequent Co-Authors

Myles Brown
Myles Brown Harvard University
Matthew L. Freedman
Matthew L. Freedman Harvard University
X. Shirley Liu
X. Shirley Liu Harvard University
William C. Hahn
William C. Hahn Dana-Farber Cancer Institute
Eliezer M. Van Allen
Eliezer M. Van Allen Harvard University
Kornelia Polyak
Kornelia Polyak Harvard University
Massimo Loda
Massimo Loda Cornell University
Ramesh A. Shivdasani
Ramesh A. Shivdasani Harvard University
Joaquim Bellmunt
Joaquim Bellmunt Beth Israel Deaconess Medical Center
Bradley E. Bernstein
Bradley E. Bernstein Broad Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in expanding your career options beyond Molecular Biology, there are a wide range of online healthcare degrees and pathways to consider. Many professionals choose to transition into advanced nursing or allied health careers, as these fields offer strong job prospects and flexible educational options.

For those curious about advancing in nursing, understanding how long to become nurse practitioner is an important consideration. Accelerated programs can help you enter the workforce quickly. For registered nurses, the fastest rn to bsn program online allows you to upgrade your credentials in as little as six months, opening doors to leadership and research roles.

If you’re a nurse looking to move into advanced practice, rn to np programs online offer streamlined pathways to become a nurse practitioner for those with varying educational backgrounds. Even non-nurses can consider transition programs such as online msn programs for non nurses to enter advanced nursing roles.

Whether your interest lies in laboratory science, patient care, or research, there are many flexible online pathways to meet your career goals and help shape the future of healthcare.

Best Scientists Citing Henry W. Long

Trending Scientists